Expertise in
1
conditions

Jan H. Soerensen

Frankfurt Am Main, HE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Frankfurt Am Main, HE, DE 

Overview

Jan Soerensen practices practicing medicine in Frankfurt Am Main, Germany.

Soerensen is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Pure Red Cell Aplasia, Anemia, Beta Thalassemia, Lipogranulomatosis, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 2 clinical trials.

Locations

Frankfurt Am Main, HE, Germany
Other Locations
Kiel, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
Allogeneic Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells of Related or Unrelated Haploidentical Donors in Pediatric Patients With Malignant and Non-malignant Diseases
Allogeneic Stem Cell Transplantation With CD3/CD19 Depleted Stem Cells of Related or Unrelated Haploidentical Donors in Pediatric Patients With Malignant and Non-malignant Diseases
Enrollment Status: Terminated
Publish Date: August 15, 2018
Intervention Type: Other
Study Phase: Phase 2
View 1 Less Clinical Trial

45 Total Publications

Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Journal: British journal of haematology
Published: January 30, 2023

Frequently Asked Questions about Jan H. Soerensen

Is Jan H. Soerensen a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Jan H. Soerensen is classified as an Advanced expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jan H. Soerensen participate in research or clinical trials?

Yes. Jan H. Soerensen has published 45 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Jan H. Soerensen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Soerensen's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile